A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapy.
Zhang Z, Ho YJ, Fang X, Kim M, Li M, Luan W, Hinterleitner C, Haubner S, Kogel F, Pratt EC, Ozcelik E, Reyes J, Jiang Q, Yang VW, Chen YJ, Wang T, Liu H, Hu H, Zhuang X, Park J, Paffenholz SV, Chen K, Chang Q, Kulick A, Zhang J, Chan E, Rosiek E, Fan N, Williams RA, Wang AC, Freeman S, Tian S, Gunset G, Garcia Angus A, Lecomte N, Yildirim SY, Ali E, Wu M, Miranda IC, Antonescu CR, Basturk O, Tarcan Z, Rekhtman N, Wilson C, Basar M, Sauter JL, Al-Ahmadie HA, Singer S, Iacobuzio-Donahue C, Rudin C, de Stanchina E, Ganesh K, Romesser PB, Weigelt B, Huh DD, Leibold J, Feucht J, Vázquez-García I, Bott MJ, Zamarin D, Shah SP, Lewis JS, Amor C, Pe'er D, Mansilla-Soto J, Filliol A, Sadelain M, Lowe SW.
Zhang Z, et al. Among authors: hinterleitner c.
Cell. 2026 Mar 30:S0092-8674(26)00269-2. doi: 10.1016/j.cell.2026.03.002. Online ahead of print.
Cell. 2026.
PMID: 41916312
Free article.